SCHEMBL30920598

SCHEMBL30920598

COc1cc2c(cc1C(=O)O)cc(CNC(=O)OC(C)(C)C)n2S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1B P49286 1/20 0.42
▸ CYP2D6 P10635 1/20 0.41
▸ PPARG P37231 5/20 0.40
▸ PPARD Q03181 2/20 0.40
▸ PPARA Q07869 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ PKM P14618 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ APEX1 P27695 1/20 0.35
▸ NOD2 Q9HC29 1/20 0.35
▸ NOD1 Q9Y239 1/20 0.35
▸ PSEN1 P49768 1/20 0.35
▸ PSEN2 P49810 1/20 0.35
▸ APH1B Q8WW43 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30920412 0.93 MTNR1B (0.41) MTNR1BCYP2D6PPARGPPARDPPARA
SCHEMBL30920593 0.91 MTNR1B (0.40) MTNR1BCYP2D6PPARGPPARDPPARA
SCHEMBL30920197 0.90 MTNR1B (0.41) MTNR1BCYP2D6PPARGPPARDPPARA
SCHEMBL30920919 0.88 CYP2D6 (0.41) MTNR1BCYP2D6PPARGPPARDPPARA
SCHEMBL30920221 0.88 CYP2D6 (0.41) MTNR1BCYP2D6PPARGPPARDPPARA
SCHEMBL30920630 0.87 MTNR1B (0.40) MTNR1BCYP2D6PPARGPPARDPPARA
SCHEMBL30920806 0.87 MTNR1B (0.40) MTNR1BCYP2D6PPARGPPARDPPARA
SCHEMBL30920703 0.85 TRPV1 (0.39) MTNR1BCYP2D6PPARGPPARDPPARA
SCHEMBL30920344 0.83 CA1 (0.39) MTNR1BPPARGPPARDPPARAKDM4E
SCHEMBL27247661 0.82 CYP2D6 (0.38) MTNR1BCYP2D6PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4601635-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF Maze Therapeutics, Inc. (US) 2025-08-20 — — EP disclosed
Send feedback